CMS welcomes comments on the extent to which, in a scenario where NDCs of multiple manufacturers are assigned to the same billing and payment code, a single manufacturer that accounts for all positive ASP units could potentially be responsible for the full rebate amount for the entire billing and payment code
Archived from the original on November 6, 2020
For drugs covered as additional preventive services, as defined at 410.64 of this subchapter, and for the administration and supplying fees for those drugs, payment to RHCs or FQHCs is 100 percent of the Medicare payment amount per 405.2410(b) and 410.152(l)(11) of this chapter, subject to the payment limitations described at 410.152(o) of this chapter
ZYN pouches were the top-selling oral nicotine brand in the U.S
We recognize the important role of gathering input and information from the CMS Innovation Center models (described in more detail in section II.G.2.a.(1) in this proposed rule), comment solicitations, research from other public and private entities, the work of all parties involved in furnishing primary care, and from the public at large
